Evaluation of the Resyca® PFSI™ soft mist inhaler for efficient delivery of mRNA-lipid nanoparticles to the Lungs

Patrick He; Vishal Chaugule; Imco Sibum; Wietze Nijdam; Nicholas Buchman; Julio Soria; Hui Xin Ong; Daniela Traini

Evaluation of the Resyca® PFSI™ soft mist inhaler for efficient delivery of mRNA-lipid nanoparticles to the Lungs

Patrick He, Vishal Chaugule, Imco Sibum, Wietze Nijdam, Nicholas Buchman, Julio Soria, Hui Xin Ong, Daniela Traini

Macquarie Medical School

Research output: Chapter in Book/Report/Conference proceeding › Conference proceeding contribution › peer-review

Original language	English
Title of host publication	RDD Europe 2025
Subtitle of host publication	Bringing the respiratory world together
Editors	R. N. Dalby, J. Peart, D. Traini, P. M. Young, J. D. Suman
Place of Publication	Portugal
Publisher	RDD Online
Pages	308-312
Number of pages	5
ISBN (Electronic)	9781739682156
ISBN (Print)	9781739682149
Publication status	Published - May 2025
Event	Respiratory Drug Delivery Europe 2025: RDD Europe 2025 - Lisbon, Portugal Duration: 6 May 2025 → 9 May 2025

Conference

Conference	Respiratory Drug Delivery Europe 2025
Country/Territory	Portugal
City	Lisbon
Period	6/05/25 → 9/05/25

Keywords

soft mist inhalers (SMIs)
mesh nebulizers
mRNA
lipid nanoparticles (LNP)

Cite this

He, P., Chaugule, V., Sibum, I., Nijdam, W., Buchman, N., Soria, J., Ong, H. X., & Traini, D. (2025). Evaluation of the Resyca® PFSI™ soft mist inhaler for efficient delivery of mRNA-lipid nanoparticles to the Lungs. In R. N. Dalby, J. Peart, D. Traini, P. M. Young, & J. D. Suman (Eds.), RDD Europe 2025: Bringing the respiratory world together (pp. 308-312). RDD Online.

@inproceedings{f507adce1d9448c8a22528de89365e46,

title = "Evaluation of the Resyca{\textregistered} PFSI{\texttrademark} soft mist inhaler for efficient delivery of mRNA-lipid nanoparticles to the Lungs",

keywords = "soft mist inhalers (SMIs), mesh nebulizers, mRNA, lipid nanoparticles (LNP)",

author = "Patrick He and Vishal Chaugule and Imco Sibum and Wietze Nijdam and Nicholas Buchman and Julio Soria and Ong, {Hui Xin} and Daniela Traini",

year = "2025",

month = may,

language = "English",

isbn = "9781739682149",

pages = "308--312",

editor = "Dalby, {R. N.} and J. Peart and D. Traini and Young, {P. M.} and Suman, {J. D.}",

booktitle = "RDD Europe 2025",

publisher = "RDD Online",

note = "Respiratory Drug Delivery Europe 2025 : RDD Europe 2025 ; Conference date: 06-05-2025 Through 09-05-2025",

}

He, P, Chaugule, V, Sibum, I, Nijdam, W, Buchman, N, Soria, J, Ong, HX & Traini, D 2025, Evaluation of the Resyca® PFSI™ soft mist inhaler for efficient delivery of mRNA-lipid nanoparticles to the Lungs. in RN Dalby, J Peart, D Traini, PM Young & JD Suman (eds), RDD Europe 2025: Bringing the respiratory world together. RDD Online, Portugal, pp. 308-312, Respiratory Drug Delivery Europe 2025, Lisbon, Portugal, 6/05/25.

Evaluation of the Resyca® PFSI™ soft mist inhaler for efficient delivery of mRNA-lipid nanoparticles to the Lungs. / He, Patrick; Chaugule, Vishal; Sibum, Imco et al.
RDD Europe 2025: Bringing the respiratory world together. ed. / R. N. Dalby; J. Peart; D. Traini; P. M. Young; J. D. Suman. Portugal: RDD Online, 2025. p. 308-312.

Research output: Chapter in Book/Report/Conference proceeding › Conference proceeding contribution › peer-review

TY - GEN

T1 - Evaluation of the Resyca® PFSI™ soft mist inhaler for efficient delivery of mRNA-lipid nanoparticles to the Lungs

AU - He, Patrick

AU - Chaugule, Vishal

AU - Sibum, Imco

AU - Nijdam, Wietze

AU - Buchman, Nicholas

AU - Soria, Julio

AU - Ong, Hui Xin

AU - Traini, Daniela

PY - 2025/5

Y1 - 2025/5

KW - soft mist inhalers (SMIs)

KW - mesh nebulizers

KW - mRNA

KW - lipid nanoparticles (LNP)

M3 - Conference proceeding contribution

SN - 9781739682149

SP - 308

EP - 312

BT - RDD Europe 2025

A2 - Dalby, R. N.

A2 - Peart, J.

A2 - Traini, D.

A2 - Young, P. M.

A2 - Suman, J. D.

PB - RDD Online

CY - Portugal

T2 - Respiratory Drug Delivery Europe 2025

Y2 - 6 May 2025 through 9 May 2025

ER -